AU2002214324A1 - Medicinal compositions - Google Patents

Medicinal compositions

Info

Publication number: AU2002214324A1
Authority: AU; Australia
Prior art keywords: medicinal compositions; medicinal; compositions
Prior art date: 2000-11-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002214324A

Other versions

AU2002214324B2 (en

Inventor

Makoto Mizuno

Toshio Sada

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Daiichi Sankyo Co Ltd

Original Assignee

Daiichi Sankyo Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-21

Filing date

2001-11-19

Publication date

2002-08-08

2001-11-19 Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd

2001-11-19 Priority claimed from PCT/JP2001/010095 external-priority patent/WO2002041890A1/en

2002-08-08 Publication of AU2002214324A1 publication Critical patent/AU2002214324A1/en

2004-07-29 Application granted granted Critical

2004-07-29 Publication of AU2002214324B2 publication Critical patent/AU2002214324B2/en

2007-09-27 Assigned to DAIICHI SANKYO COMPANY, LIMITED reassignment DAIICHI SANKYO COMPANY, LIMITED Request for Assignment Assignors: SANKYO COMPANY, LIMITED

2021-11-19 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Links

AU2002214324A 2000-11-21 2001-11-19 Medicinal compositions Expired AU2002214324B2 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2000354327		2000-11-21
JP2000-354327		2000-11-21
JP2001-164009		2001-05-31
JP2001164009		2001-05-31
PCT/JP2001/010095 WO2002041890A1 (en)	2000-11-21	2001-11-19	Medicinal compositions

Publications (2)

Publication Number	Publication Date
AU2002214324A1 true AU2002214324A1 (en)	2002-08-08
AU2002214324B2 AU2002214324B2 (en)	2004-07-29

Family

ID=26604360

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AU1432402A Pending AU1432402A (en)	2000-11-21	2001-11-19	Medicinal compositions
AU2002214324A Expired AU2002214324B2 (en)	2000-11-21	2001-11-19	Medicinal compositions

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU1432402A Pending AU1432402A (en)	2000-11-21	2001-11-19	Medicinal compositions

Country Status (23)

Country	Link
US (2)	US6878703B2 (en)
EP (2)	EP1595540A1 (en)
KR (1)	KR100656716B1 (en)
CN (1)	CN1265788C (en)
AT (1)	ATE324890T1 (en)
AU (2)	AU1432402A (en)
BR (1)	BR0115516A (en)
CA (1)	CA2429260A1 (en)
CY (1)	CY1106134T1 (en)
CZ (1)	CZ20031367A3 (en)
DE (1)	DE60119368T2 (en)
DK (1)	DK1336407T3 (en)
ES (1)	ES2262689T3 (en)
HU (1)	HUP0400553A3 (en)
IL (2)	IL155965A0 (en)
MX (1)	MXPA03004463A (en)
NO (1)	NO332938B1 (en)
NZ (1)	NZ525913A (en)
PL (1)	PL207252B1 (en)
PT (1)	PT1336407E (en)
SK (1)	SK5992003A3 (en)
TW (1)	TWI262076B (en)
WO (1)	WO2002041890A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BRPI0406987A (en) *	2003-01-31	2006-01-10	Sankyo Co	Medicament for the prevention and / or treatment of atherosclerosis, medicaments for inhibiting vascular smooth muscle cell proliferation, neointimal formation of blood vessels and vascular remodeling, medicament for the prevention of restenosis following percutaneous coronary intervention, and, medicines for the prophylaxis and / or treatment of hypertension or diseases caused by hypertension or diseases caused by hypertension, heart disease, angina pectoris, myocardial infarction, arrhythmia, sudden death, heart failure, cardiac hypertrophy, kidney diseases, diabetic nephropathy, glomerulonephritis, nephrosclerosis, cerebrovascular diseases, cerebral infarction, and cerebral hemorrhage
US20040198789A1 (en) *	2003-02-28	2004-10-07	Recordati Ireland Limited	Lercanidipine/ARB/diuretic therapeutic combinations
CA2536975A1 (en)	2003-08-28	2005-03-17	Nitromed, Inc.	Nitrosated and nitrosylated diuretic compounds, compositions and methods of use
US20070054948A1 (en) *	2004-09-02	2007-03-08	Lilach Hedvati	Purification of olmesartan medoxomil
WO2006029056A1 (en) *	2004-09-02	2006-03-16	Teva Pharmaceutical Industries Ltd.	Preparation of olmesartan medoxomil
JP4437141B2 (en) *	2004-09-02	2010-03-24	テバファーマシューティカルインダストリーズリミティド	Purification method of olmesartan medoxomil
EP1855688A4 (en)	2005-02-24	2011-09-14	Nicox Sa	Nitric oxide enhancing diuretic compounds, compositions and methods of use
JP4979577B2 (en) *	2005-05-20	2012-07-18	第一三共株式会社	Dextrose-containing film coating formulation
JP5000491B2 (en) *	2005-05-20	2012-08-15	第一三共株式会社	Film coating formulation
WO2007047838A2 (en) *	2005-10-20	2007-04-26	Dr. Reddy's Laboratories Ltd.	Process for preparing olmesartan medoxomil
US8077769B2 (en) *	2006-03-28	2011-12-13	Sony Corporation	Method of reducing computations in transform and scaling processes in a digital video encoder using a threshold-based approach
ATE526963T1 (en) *	2006-05-04	2011-10-15	Lek Pharmaceuticals	PHARMACEUTICAL COMPOSITION CONTAINING OLMESARTAN-MEDOXOMIL
JP2010508266A (en) *	2006-10-30	2010-03-18	ハナルファーマシューティカルカンパニーリミテッド	Controlled release pharmaceutical composition comprising a thiazide compound and an angiotensin-II-receptor blocker
US20110038898A1 (en)	2008-03-13	2011-02-17	Shuichi Yada	Dissolution properties of drug products containing olmesartan medoxomil
US20100008956A1 (en) *	2008-07-08	2010-01-14	Jie Du	Composition and combinations of carboxylic acid losartan in dosage forms
DE102008059206A1 (en)	2008-11-27	2010-06-10	Bayer Schering Pharma Aktiengesellschaft	Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
US9387249B2 (en)	2008-12-23	2016-07-12	Takeda Pharmaceutical Company Limited	Methods of treating hypertension with at least one angiotensin II receptor blocker and chlorthalidone
IT1400311B1 (en)	2010-05-10	2013-05-24	Menarini Int Operations Lu Sa	ASSOCIATION OF INHIBITORS OF XANTHIN OXIDASE AND ANTAGONISTS OF THE Angiotensin II RECEPTOR AND THEIR USE.
AU2019287551A1 (en)	2018-06-14	2021-01-28	Astrazeneca Uk Limited	Methods for treatment of hypertension with an angiotensin II receptor blocker pharmaceutical composition

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3009911A (en)		1961-11-21		Derivatives of j
US2783241A (en)		1957-02-26		S-acylimino-x-substituted-az-i
US3254076A (en)		1966-05-31		Sulfamyl hydro
US3108097A (en)		1963-10-22		Ehnojs
US3025292A (en)		1962-03-13		Reduction of i
US2976289A (en)		1961-03-21		X-tetrahydro -
US2554816A (en)	1950-04-04	1951-05-29	American Cyanamid Co	Heterocyclic sulfonamides and methods of preparation thereof
GB795174A (en)	1954-10-13	1958-05-21	Upjohn Co	Heterocyclic sulphonamides
US2835702A (en)	1956-05-02	1958-05-20	Merck & Co Inc	Benzene 1, 3 disulfonamides possessing diuretic properties
US2980679A (en)	1957-04-04	1961-04-18	Omikron Gagliardi Societa Di F	Process for preparing heterocyclic sulfonamides
US3055904A (en)	1957-11-04	1962-09-25	Geigy Chem Corp	New isoindoline derivatives
GB851287A (en)	1958-07-10	1960-10-12	British Drug Houses Ltd	5-chlorotoluene-2:4-disulphonamide and alkali metal salts thereof
US3058882A (en)	1959-12-28	1962-10-16	Hoechst Ag	N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3255241A (en)	1961-01-19	1966-06-07	Merck & Co Inc	(2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids
GB979994A (en)	1961-07-28	1965-01-06	May & Baker Ltd	Isoindolinone derivatives
US3265573A (en)	1962-07-27	1966-08-09	Squibb & Sons Inc	Benzothiadiazinesulfonamide-1, 1-dioxide composition
BE639386A (en)	1962-10-30
DE1278443C2 (en)	1963-11-30	1975-07-24	Bayer Ag, 5090 Leverkusen	PROCESS FOR THE PREPARATION OF 2,4-DISULFONAMIDE-1-CHLOROBENZENE
US3163645A (en)	1964-09-25	1964-12-29	Ciba Geigy Corp	Derivatives of 3, 4-dihydro-2-h-[1, 2, 4]-benzothiadiazine-1, 1-dioxides
DE1270544B (en)	1965-06-19	1968-06-20	Beiersdorf Ag	4-chloro-5-sulfamylsalicylic acid (2 ', 6'-dimethyl) anilide and its alkali or ammonium salts and processes for their preparation
US3360518A (en)	1966-01-03	1967-12-26	Wallace & Tiernan Inc	Tetrahydro-halo-sulfamyl quinazolinones
US3634583A (en)	1969-07-24	1972-01-11	Leo Pharm Prod Ltd	Pharmaceutical composition for the treatment of oedematous conditions and hypertension
BE757001A (en)	1969-10-10	1971-03-16	Cerpha	HETEROCYCLIC DERIVATIVES OF PHENOXY ACETIC ACIDS AND THEIR PREPARATION
US5138069A (en)	1986-07-11	1992-08-11	E. I. Du Pont De Nemours And Company	Angiotensin II receptor blocking imidazoles
CA1338238C (en) *	1988-01-07	1996-04-09	David John Carini	Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
EP0733366B1 (en) *	1988-01-07	1998-04-01	E.I. Du Pont De Nemours And Company	Pharmaceutical compositions comprising angiotensin II receptor blocking imidazoles and diuretics
CA2016710A1 (en) *	1989-05-15	1990-11-15	Prasun K. Chakravarty	Substituted benzimidazoles as angiotensin ii antagonists
US5656650A (en) *	1990-12-14	1997-08-12	Smithkline Beecham Corp.	Angiotensin II receptor blocking compositions
FI112942B3 (en) *	1991-02-21	2012-03-13	Daiichi Sankyo Co Ltd	Process for the preparation of 4 '- (1H-imidazol-1-ylmethyl) -1,1'-biphenyl derivatives useful for treating and preventing high blood pressure
US5616599A (en) *	1991-02-21	1997-04-01	Sankyo Company, Limited	Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5310928A (en)	1991-11-18	1994-05-10	E. I. Du Pont De Nemours And Company	Process for preparing biphenyltetrazole compounds
US5264447A (en) *	1992-09-01	1993-11-23	Merck & Co., Inc.	Angiotensin II antagonist

2001
- 2001-11-19 AT AT01982846T patent/ATE324890T1/en active
- 2001-11-19 AU AU1432402A patent/AU1432402A/en active Pending
- 2001-11-19 ES ES01982846T patent/ES2262689T3/en not_active Expired - Lifetime
- 2001-11-19 PL PL361093A patent/PL207252B1/en unknown
- 2001-11-19 MX MXPA03004463A patent/MXPA03004463A/en active IP Right Grant
- 2001-11-19 HU HU0400553A patent/HUP0400553A3/en unknown
- 2001-11-19 CN CNB018221130A patent/CN1265788C/en not_active Expired - Lifetime
- 2001-11-19 DK DK01982846T patent/DK1336407T3/en active
- 2001-11-19 NZ NZ525913A patent/NZ525913A/en not_active IP Right Cessation
- 2001-11-19 PT PT01982846T patent/PT1336407E/en unknown
- 2001-11-19 CA CA002429260A patent/CA2429260A1/en not_active Abandoned
- 2001-11-19 BR BR0115516-4A patent/BR0115516A/en not_active Application Discontinuation
- 2001-11-19 SK SK599-2003A patent/SK5992003A3/en not_active Application Discontinuation
- 2001-11-19 CZ CZ20031367A patent/CZ20031367A3/en unknown
- 2001-11-19 WO PCT/JP2001/010095 patent/WO2002041890A1/en not_active Ceased
- 2001-11-19 KR KR1020037006752A patent/KR100656716B1/en not_active Ceased
- 2001-11-19 EP EP05008297A patent/EP1595540A1/en not_active Withdrawn
- 2001-11-19 IL IL15596501A patent/IL155965A0/en unknown
- 2001-11-19 EP EP01982846A patent/EP1336407B1/en not_active Revoked
- 2001-11-19 AU AU2002214324A patent/AU2002214324B2/en not_active Expired
- 2001-11-19 DE DE60119368T patent/DE60119368T2/en not_active Expired - Lifetime
- 2001-11-21 TW TW090128798A patent/TWI262076B/en not_active IP Right Cessation
2003
- 2003-05-18 IL IL155965A patent/IL155965A/en unknown
- 2003-05-20 US US10/442,874 patent/US6878703B2/en not_active Expired - Fee Related
- 2003-05-20 NO NO20032261A patent/NO332938B1/en not_active IP Right Cessation
2004
- 2004-12-23 US US11/020,624 patent/US20050113367A1/en not_active Abandoned
2006
- 2006-07-31 CY CY20061101069T patent/CY1106134T1/en unknown

Publication	Publication Date	Title
AU781269C (en)	2006-11-30	Pharmaceutical compositions
AU2001250420A1 (en)	2001-10-23	Pharmaceutical compositions
AU2001274307A1 (en)	2002-01-02	Pharmaceutical compositions
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU3192700A (en)	2000-10-04	Medicinal compositions
AU2005300A (en)	2000-08-07	Medicinal compositions
AU2002258221A1 (en)	2003-05-08	Medicinal composition
AU2002214324A1 (en)	2002-08-08	Medicinal compositions
AUPQ875700A0 (en)	2000-08-03	Combination compositions
AU8576801A (en)	2002-01-02	Pharmaceutical compositions
AU2001290239A1 (en)	2002-04-02	Medicinal composition
HUP0400553A3 (en)	2010-03-29	Pharmaceutical compositions
AU2002221115A1 (en)	2002-06-24	Medicinal compositions having improved absorbability
AU1390002A (en)	2002-03-22	Pharmaceutical compositions
AU2001273919A1 (en)	2001-10-23	Pharmaceutical compositions
AU2002210433A1 (en)	2002-02-05	Dental compositions
AU2001270235A1 (en)	2002-01-14	Oral compositions
AU4085201A (en)	2001-09-24	Pharmaceutical composition
AU2001235764A1 (en)	2001-09-03	Compositions
AU2001290669A1 (en)	2002-03-26	Oral compositions
AU2001223721A1 (en)	2001-07-24	Dental compositions
AU3586401A (en)	2001-09-17	Pharmaceutical composition
AU2001282541A1 (en)	2002-06-13	Medicinal compositions
AU2002354460A1 (en)	2003-07-09	Medicinal composition
AU2001278788A1 (en)	2002-03-04	Oral composition